AdBoards

DeciBio conducted financial projections, valuation, and assisted with messaging to aid client's public listing to NASDAQ

A global healthcare investment firm wanted to perform a commercial due diligence (CDD) prior to investment in a company producing a novel handheld diagnostic.

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

A top-10 biopharma wanted to assess how the biomarker testing and treatment landscape would change, and the potential impact on the use of their drug, in response to a recent approval of a new competing cancer therapy approved in earlier lines of treatment

A leader in research tools and clinical diagnostic development asked us to evaluate the opportunity for an ultrasensitive detection platform in methylation analysis

A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx